Anthropic is expanding the capabilities of its AI assistant, Claude, by rolling out new features that allow the tool to work more closely with Microsoft Excel and PowerPoint. The update is designed to ...

Blake has over a decade of experience writing for the web, with a focus on mobile phones, where he covered the smartphone boom of the 2010s and the broader tech scene. When he's not in front of a ...

Anthropic has upgraded its Claude AI model with new capabilities for Microsoft Excel and PowerPoint, marking a strategic move to expand its enterprise footprint and potentially challenging Microsoft’s ...

Anthropic is embedding AI more deeply in popular work software tools. Claude AI now integrates with Excel, PowerPoint, and Slack, enhancing enterprise productivity. Anthropic challenges Microsoft, ...

Quantum computers—devices that process information using quantum mechanical effects—have long been expected to outperform classical systems on certain tasks. Over the past few decades, researchers ...

With the release of Claude Opus 4.6 earlier this month, Anthropic rolled out a new Microsoft PowerPoint extension for its chatbot. Initially launched as a research preview for users on the Max, Team, ...

If you regularly deliver the same presentation, you may need to make small adjustments for different audiences or time constraints–for example, by omitting some slides. In PowerPoint, you can save ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

If PowerPoint opens a blank presentation with name but content not showing, the solutions provided in this article will help you. This problem can occur due to several causes, such as a corrupt ...

Among people with sickle cell disease—an inherited blood disorder—acute chest syndrome (ACS) is the leading cause of death. The condition is the result of red blood cells becoming stiff, sticky, and ...

ARO-C3 treatment led to deep and sustained reductions in alternative pathway complement activity and proteinuria. ARO-C3, an investigational RNA interference-based therapy targeting hepatic expression ...